PNC Financial Services Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3K Hold
4,600
– – ﹤0.01% 3933
2026
Q1
$12.4K Hold
4,600
– – ﹤0.01% 3880
2025
Q4
$10.1K Buy
4,600
+4,000
+667% +$9.91K ﹤0.01% 3947
2025
Q3
$1.4K Sell
600
-709
-54% -$1.22K ﹤0.01% 4594
2025
Q2
$1.99K Buy
1,309
+1,155
+750% +$1.8K ﹤0.01% 4414
2025
Q1
$214 Buy
154
+82
+114% +$175 ﹤0.01% 4770
2024
Q4
$163 Buy
+72
New +$253 ﹤0.01% 4667
2024
Q3
– Sell
-479
Closed -$3.58K – 4803
2024
Q2
$3.58K Sell
479
-42
-8% -$515 ﹤0.01% 4090
2024
Q1
$8.89K Sell
521
-169
-24% -$3.63K ﹤0.01% 3790
2023
Q4
$15.7K Sell
690
-96
-12% -$1.61K ﹤0.01% 3565
2023
Q3
$12K Buy
786
+72
+10% +$984 ﹤0.01% 3668
2023
Q2
$9.22K Buy
714
+138
+24% +$1.5K ﹤0.01% 3908
2023
Q1
$4.76K Buy
+576
New +$5.39K ﹤0.01% 4055

Other funds holding CABA

PNC Financial Services Group's CABA Position: Q2 2026 in Review

PNC Financial Services Group held its Cabaletta Bio (CABA) position steady in Q2 2026 at 4,600 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3933.

PNC Financial Services Group first reported a position in CABA in Q1 2023 and has held it in 13 quarters since. The position peaked at $15.7K in Q4 2023. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • PNC Financial Services Group held 4,600 shares of Cabaletta Bio worth $14.3K as of Q2 2026.
  • PNC Financial Services Group left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3933 holding.
  • PNC Financial Services Group first reported a position in Cabaletta Bio in Q1 2023 and has held it in 13 quarters since.
  • PNC Financial Services Group's Cabaletta Bio position peaked at $15.7K in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.